Kotak Institutional Equities has reiterated its bullish stance on Lodha Developers, assigning a "BUY" call with a revised fair value of Rs1,500 per share.

Kotak Institutional Equities has struck a bullish note on Piramal Pharma with its latest research, reiterating a BUY recommendation and projecting a fair value of Rs305 per share against a current

Kotak Institutional Equities has reiterated its bullish stance on Acme Solar Holdings (ACMESOLA), assigning a “BUY” call with an upgraded fair value of Rs350 per share.

Kotak Institutional Equities has reiterated a BUY rating on Home First Finance Company (HFFC), setting a revised Fair Value target of Rs1,560.

Anand Rathi Share and Stock Brokers has initiated coverage on Hindustan Aeronautics (HAL), bestowing a 'Buy' rating and setting a 12-month target price of Rs 5,950, implying considerable upside fro

ICICI Securities has reiterated its bullish stance on SBI Life Insurance Company, maintaining its BUY rating while hiking the target price to Rs2,140 per share from its earlier Rs1,950.